BP - A Beneficencia Portuguesa de São Paulo-Medical Oncology ( Site 0214)

São Paulo 01321-001

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Nonsquamous Non-small-cell Lung

Studies at this site

• Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006) — Completed